Abstract:
New indications for meniscal allograft transplantation (MAT) are being added, but the general expert opinion is that it is still a procedure reserved for symptomatic meniscal loss.
Lateral MAT has better clinical outcomes and less failure risk compared to medial MAT.
Ideal conditions (low-grade chondral lesions) make MAT a more survivable and successful procedure.
Meniscal extrusion after MAT is common and does not seem to alter results.
Midterm survivorship of a MAT is reported to be 85–90%, while long-term survivorship decreases to 50–70% depending on chondral status and concomitant procedures.
Even if the procedure is a success, there are high possibilities of not being able to resume sports activities.
